AMN Stock Recent News
AMN LATEST HEADLINES
The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DALLAS, Oct. 05, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its third quarter 2023 financial results and fourth quarter 2023 outlook on Thursday, November 2, 2023, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.
AMN, ARR and CFBK have been added to the Zacks Rank #5 (Strong Sell) List on September 6, 2023.
AFCG, AMN and DNOW have been added to the Zacks Rank #5 (Strong Sell) List on August 30, 2023.
While many financial advisors will direct you to established public enterprises, investors seeking some “oomph” for their portfolio may want to target “unmatched” stocks with potential. Rather than walking along the beaten path, these lesser-known entities carry significantly higher risk.
While time in the market usually beats out timing the market, one can certainly appreciate the desire of holding out for underrated stocks to buy. Specifically, even with the latest rumblings in the equities space, the benchmark S&P 500 index offers well into double-digit returns so far this year.
AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall Q2 performance.
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $3.31 per share a year ago.
AMN Healthcare (AMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.